| SCLC | Small-cell lung cancer |
| ES-SCLC | Extensive-stage small-cell lung cancer |
| LS-SCLC | Limited-stage small-cell lung cancer |
| NSCLC | Non-small cell lung cancer |
| NCDB | National Cancer Database |
| PFS | Progression-free survival |
| OS | Overall survival |
| CRT | Chemoradiotherapy |
| Chemo | Chemotherapy |
| IO | Immunotherapy |
| ICIs | Immune checkpoint inhibitors |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| ICD | Immunogenic cell death |
| EP | Etoposide-platinum |
| PS | Propensity scores |
| IPTW | Inverse probability of treatment weighting |
| OW | Overlap weights |
| ASMD | Absolute standardized mean differences |
| PH | Proportional hazards |
| HR | Hazard ratio |
| CIs | Confidence intervals |
| KM | Kaplan-Meier |
| RMST | Restricted mean survival time |
| SD | Standard deviation |